United States Parkinsons Disease Drug Market Report 2016

October 2016 | 123 pages | ID: U33B415AC7AEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Parkinsons Disease Drug

Revenue, means the sales value of Parkinsons Disease Drug

This report studies sales (consumption) of Parkinsons Disease Drug in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• GSK
• Novartis
• Boehringer Ingelheim
• Teva Pharmaceutical
• Abbvie
• Merck
• Akorn
• Astellas Pharma
• Desitin Arzneimittel
• Endo Pharmaceuticals
• F.Hoffmann-La Roche
• H.Lundbeck
• Kyowa Hakko Kirin Pharma
• Orion
• Stada Arzneimittel
• Valeant
• Apokyn

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Parkinsons Disease Drug in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Parkinsons Disease Drug Market Report 2016

1 PARKINSONS DISEASE DRUG OVERVIEW

1.1 Product Overview and Scope of Parkinsons Disease Drug
1.2 Classification of Parkinsons Disease Drug
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Parkinsons Disease Drug
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 USA Market Size Sales (Value) and Revenue (Volume) of Parkinsons Disease Drug (2011-2021)
  1.4.1 USA Parkinsons Disease Drug Sales and Growth Rate (2011-2021)
  1.4.2 USA Parkinsons Disease Drug Revenue and Growth Rate (2011-2021)

2 USA PARKINSONS DISEASE DRUG COMPETITION BY MANUFACTURERS

2.1 USA Parkinsons Disease Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Parkinsons Disease Drug Revenue and Share by Manufactures (2015 and 2016)
2.3 USA Parkinsons Disease Drug Average Price by Manufactures (2015 and 2016)
2.4 Parkinsons Disease Drug Market Competitive Situation and Trends
  2.4.1 Parkinsons Disease Drug Market Concentration Rate
  2.4.2 Parkinsons Disease Drug Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 USA PARKINSONS DISEASE DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 USA Parkinsons Disease Drug Sales and Market Share by Type (2011-2016)
3.2 USA Parkinsons Disease Drug Revenue and Market Share by Type (2011-2016)
3.3 USA Parkinsons Disease Drug Price by Type (2011-2016)
3.4 USA Parkinsons Disease Drug Sales Growth Rate by Type (2011-2016)

4 USA PARKINSONS DISEASE DRUG SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 USA Parkinsons Disease Drug Sales and Market Share by Application (2011-2016)
4.2 USA Parkinsons Disease Drug Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 USA PARKINSONS DISEASE DRUG MANUFACTURERS PROFILES/ANALYSIS

5.1 GSK
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Parkinsons Disease Drug Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 GSK Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Novartis
  5.2.2 Parkinsons Disease Drug Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Novartis Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Boehringer Ingelheim
  5.3.2 Parkinsons Disease Drug Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Boehringer Ingelheim Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Teva Pharmaceutical
  5.4.2 Parkinsons Disease Drug Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Teva Pharmaceutical Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Abbvie
  5.5.2 Parkinsons Disease Drug Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Abbvie Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Merck
  5.6.2 Parkinsons Disease Drug Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Merck Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Akorn
  5.7.2 Parkinsons Disease Drug Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Akorn Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Astellas Pharma
  5.8.2 Parkinsons Disease Drug Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Astellas Pharma Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Desitin Arzneimittel
  5.9.2 Parkinsons Disease Drug Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Desitin Arzneimittel Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Endo Pharmaceuticals
  5.10.2 Parkinsons Disease Drug Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Endo Pharmaceuticals Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 F.Hoffmann-La Roche
5.12 H.Lundbeck
5.13 Kyowa Hakko Kirin Pharma
5.14 Orion
5.15 Stada Arzneimittel
5.16 Valeant
5.17 Apokyn

6 PARKINSONS DISEASE DRUG MANUFACTURING COST ANALYSIS

6.1 Parkinsons Disease Drug Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Parkinsons Disease Drug

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Parkinsons Disease Drug Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Parkinsons Disease Drug Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 USA PARKINSONS DISEASE DRUG MARKET FORECAST (2016-2021)

10.1 USA Parkinsons Disease Drug Sales, Revenue Forecast (2016-2021)
10.2 USA Parkinsons Disease Drug Sales Forecast by Type (2016-2021)
10.3 USA Parkinsons Disease Drug Sales Forecast by Application (2016-2021)
10.4 Parkinsons Disease Drug Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Parkinsons Disease Drug
Table Classification of Parkinsons Disease Drug
Figure USA Sales Market Share of Parkinsons Disease Drug by Type in 2015
Table Application of Parkinsons Disease Drug
Figure USA Sales Market Share of Parkinsons Disease Drug by Application in 2015
Figure USA Parkinsons Disease Drug Sales and Growth Rate (2011-2021)
Figure USA Parkinsons Disease Drug Revenue and Growth Rate (2011-2021)
Table USA Parkinsons Disease Drug Sales of Key Manufacturers (2015 and 2016)
Table USA Parkinsons Disease Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Parkinsons Disease Drug Sales Share by Manufacturers
Figure 2016 Parkinsons Disease Drug Sales Share by Manufacturers
Table USA Parkinsons Disease Drug Revenue by Manufacturers (2015 and 2016)
Table USA Parkinsons Disease Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Parkinsons Disease Drug Revenue Share by Manufacturers
Table 2016 USA Parkinsons Disease Drug Revenue Share by Manufacturers
Table USA Market Parkinsons Disease Drug Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market Parkinsons Disease Drug Average Price of Key Manufacturers in 2015
Figure Parkinsons Disease Drug Market Share of Top 3 Manufacturers
Figure Parkinsons Disease Drug Market Share of Top 5 Manufacturers
Table USA Parkinsons Disease Drug Sales by Type (2011-2016)
Table USA Parkinsons Disease Drug Sales Share by Type (2011-2016)
Figure USA Parkinsons Disease Drug Sales Market Share by Type in 2015
Table USA Parkinsons Disease Drug Revenue and Market Share by Type (2011-2016)
Table USA Parkinsons Disease Drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Parkinsons Disease Drug by Type (2011-2016)
Table USA Parkinsons Disease Drug Price by Type (2011-2016)
Figure USA Parkinsons Disease Drug Sales Growth Rate by Type (2011-2016)
Table USA Parkinsons Disease Drug Sales by Application (2011-2016)
Table USA Parkinsons Disease Drug Sales Market Share by Application (2011-2016)
Figure USA Parkinsons Disease Drug Sales Market Share by Application in 2015
Table USA Parkinsons Disease Drug Sales Growth Rate by Application (2011-2016)
Figure USA Parkinsons Disease Drug Sales Growth Rate by Application (2011-2016)
Table GSK Basic Information List
Table GSK Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GSK Parkinsons Disease Drug Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Parkinsons Disease Drug Sales Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim Parkinsons Disease Drug Sales Market Share (2011-2016)
Table Teva Pharmaceutical Basic Information List
Table Teva Pharmaceutical Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Parkinsons Disease Drug Sales Market Share (2011-2016)
Table Abbvie Basic Information List
Table Abbvie Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbvie Parkinsons Disease Drug Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Parkinsons Disease Drug Sales Market Share (2011-2016)
Table Akorn Basic Information List
Table Akorn Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Akorn Parkinsons Disease Drug Sales Market Share (2011-2016)
Table Astellas Pharma Basic Information List
Table Astellas Pharma Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Astellas Pharma Parkinsons Disease Drug Sales Market Share (2011-2016)
Table Desitin Arzneimittel Basic Information List
Table Desitin Arzneimittel Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Desitin Arzneimittel Parkinsons Disease Drug Sales Market Share (2011-2016)
Table Endo Pharmaceuticals Basic Information List
Table Endo Pharmaceuticals Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Endo Pharmaceuticals Parkinsons Disease Drug Sales Market Share (2011-2016)
Table F.Hoffmann-La Roche Basic Information List
Table F.Hoffmann-La Roche Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table F.Hoffmann-La Roche Parkinsons Disease Drug Sales Market Share (2011-2016)
Table H.Lundbeck Basic Information List
Table H.Lundbeck Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table H.Lundbeck Parkinsons Disease Drug Sales Market Share (2011-2016)
Table Kyowa Hakko Kirin Pharma Basic Information List
Table Kyowa Hakko Kirin Pharma Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kyowa Hakko Kirin Pharma Parkinsons Disease Drug Sales Market Share (2011-2016)
Table Orion Basic Information List
Table Orion Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Orion Parkinsons Disease Drug Sales Market Share (2011-2016)
Table Stada Arzneimittel Basic Information List
Table Stada Arzneimittel Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Stada Arzneimittel Parkinsons Disease Drug Sales Market Share (2011-2016)
Table Valeant Basic Information List
Table Valeant Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Valeant Parkinsons Disease Drug Sales Market Share (2011-2016)
Table Apokyn Basic Information List
Table Apokyn Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Apokyn Parkinsons Disease Drug Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Parkinsons Disease Drug
Figure Manufacturing Process Analysis of Parkinsons Disease Drug
Figure Parkinsons Disease Drug Industrial Chain Analysis
Table Raw Materials Sources of Parkinsons Disease Drug Major Manufacturers in 2015
Table Major Buyers of Parkinsons Disease Drug
Table Distributors/Traders List
Figure USA Parkinsons Disease Drug Production and Growth Rate Forecast (2016-2021)
Figure USA Parkinsons Disease Drug Revenue and Growth Rate Forecast (2016-2021)
Table USA Parkinsons Disease Drug Production Forecast by Type (2016-2021)
Table USA Parkinsons Disease Drug Consumption Forecast by Application (2016-2021)